Rice Hall James & Associates LLC Purchases New Position in Varex Imaging $VREX

Rice Hall James & Associates LLC acquired a new stake in Varex Imaging (NASDAQ:VREX) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 1,445,853 shares of the company’s stock, valued at approximately $15,080,000. Rice Hall James & Associates LLC owned 3.43% of Varex Imaging at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Empowered Funds LLC lifted its position in shares of Varex Imaging by 7.3% during the 1st quarter. Empowered Funds LLC now owns 179,128 shares of the company’s stock valued at $2,078,000 after buying an additional 12,151 shares in the last quarter. Jane Street Group LLC grew its stake in Varex Imaging by 17.9% in the 1st quarter. Jane Street Group LLC now owns 159,362 shares of the company’s stock valued at $1,849,000 after acquiring an additional 24,160 shares during the period. Rhumbline Advisers increased its holdings in Varex Imaging by 4.6% in the 2nd quarter. Rhumbline Advisers now owns 61,820 shares of the company’s stock worth $536,000 after acquiring an additional 2,694 shares in the last quarter. Hsbc Holdings PLC increased its holdings in Varex Imaging by 19.7% in the 2nd quarter. Hsbc Holdings PLC now owns 47,525 shares of the company’s stock worth $408,000 after acquiring an additional 7,825 shares in the last quarter. Finally, Quantbot Technologies LP raised its position in Varex Imaging by 25.1% during the second quarter. Quantbot Technologies LP now owns 47,292 shares of the company’s stock worth $410,000 after acquiring an additional 9,476 shares during the period.

Analyst Ratings Changes

Several equities analysts have issued reports on VREX shares. CJS Securities downgraded shares of Varex Imaging from an “outperform” rating to a “market perform” rating in a report on Monday. Zacks Research cut shares of Varex Imaging from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 27th. Oppenheimer downgraded shares of Varex Imaging from an “outperform” rating to a “market perform” rating in a research report on Monday, August 10th. Weiss Ratings raised shares of Varex Imaging from a “sell (d-)” rating to a “sell (d+)” rating in a research note on Tuesday, August 11th. Finally, Wall Street Zen upgraded Varex Imaging from a “hold” rating to a “buy” rating in a report on Saturday, July 4th. Six investment analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Reduce” and a consensus target price of $16.88.

Varex Imaging Stock Down 0.2%

NASDAQ VREX opened at $18.46 on Tuesday. The business has a fifty day moving average price of $11.77 and a 200 day moving average price of $11.70. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.53 and a current ratio of 3.38. The company has a market cap of $777.17 million, a P/E ratio of 35.50 and a beta of 0.89. Varex Imaging has a one year low of $9.09 and a one year high of $18.63.

Varex Imaging (NASDAQ:VREX) last announced its earnings results on Monday, August 10th. The company reported $0.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.21 by $0.10. Varex Imaging had a net margin of 2.55% and a return on equity of 9.19%. The company had revenue of $210.50 million for the quarter, compared to analysts’ expectations of $215.50 million. Research analysts anticipate that Varex Imaging will post 0.93 EPS for the current fiscal year.

Varex Imaging Profile

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.